Wistar Scientists Engineer New NK cell Engaging Immunotherapy Approaches to Target and Potentially Treat Recalcitrant Ovarian Cancer
PHILADELPHIA, PA — The Wistar Institute’s David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center (VIC) and W.W. Smith Charitable Trust Distinguished Professor in Cancer Research, and collaborators, …
Wistar Scientists Engineer New NK cell Engaging Immunotherapy Approaches to Target and Potentially Treat Recalcitrant Ovarian Cancer Read More